MELK and central nervous system cancer: In addition, the expression levels of MELK in patients with primary, recurrent, and secondary gliomas were also analyzed, and statistics showed that MELK expression in patients recurrent and secondary gliomas was markedly upregulated compared with that in patients with primary glioma (Figure 2D).